| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/9/267:00 AM | -$3.64 | -$3.23GAAP | +11.3% | +4% | $485K | $0 | -100% | — | |
| Q2 '26 | 8/6/268:00 AM | -$3.67 | -$2.87GAAP | +21.8% | +13% | — | $0 | — | — | |
| Q1 '26 | 5/7/267:30 AM | -$3.66 | -$3.20GAAP | +12.6% | +3% | — | $0 | — | — | |
| Q4 '25 | 2/19/267:30 AM | -$3.08 | -$3.50GAAP | -13.6% | -19% | $256K | $0 | -100% | -100% | |
| Q3 '25 | 11/5/257:00 AM | -$3.47 | -$3.36GAAP | +3.2% | -22% | $59K | $0 | -100% | -100% | |
| Q2 '25 | 8/4/257:00 AM | -$3.37 | -$3.31GAAP | +1.8% | -90% | $210K | $0 | -100% | -100% | |
| Q1 '25 | 5/2/257:00 AM | -$3.20 | -$3.29GAAP | -2.8% | -16% | $183K | $0 | -100% | -100% |
GAAP = diluted EPS as filed with the SEC.